Open Label, Uncontrolled, Non-randomized, Single Dose, Scintigraphic Study to Investigate Lung Deposition of Inhaled 99mTc Radiolabelled CHF5993 pMDI in Healthy Volunteers, Asthmatic and COPD Patients
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Chiesi Farmaceutici SpA
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 06 Apr 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Dec 2016 New trial record